Changing the Tumor Microenvironment: New Strategies for Immunotherapy

被引:22
作者
Berraondo, Pedro [1 ]
Umansky, Viktor [2 ,3 ]
Melero, Ignacio [1 ]
机构
[1] Univ Navarra, Univ Navarra Clin, Ctr Appl Med Res, Div Hepatol & Gene Therapy, Navarra, Spain
[2] German Canc Res Ctr, Skin Canc Unit, D-6900 Heidelberg, Germany
[3] Univ Hosp Mannheim, Heidelberg, Germany
关键词
ADVANCED MELANOMA PATIENTS; CANCER; ANTIBODY; IPILIMUMAB; EXPRESSION; SAFETY;
D O I
10.1158/0008-5472.CAN-12-1952
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Solid tumors are composed of malignant cells surrounded by a tumor-conditioned stroma that contains extracellular matrix and a variety of nonmalignant populations, including myeloid cells, lymphocytes, fibroblasts, and endothelial cells. These stromal elements form a local immunoregulatory network that must be overcome to achieve eradication of established tumors by immunotherapy. On March 21-22, 2012, a symposium was held in Pamplona, Spain, to share the recent advances regarding the molecules and cells that create and sustain this immune-hostile tumor microenvironment. Excellent targets for immunotherapeutic intervention were identified, and a number of therapeutic strategies under translation from mouse to human were presented. Cancer Res; 72(20); 5159-64. (C)2012 AACR.
引用
收藏
页码:5159 / 5164
页数:6
相关论文
共 26 条
  • [1] Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
    Brahmer, Julie R.
    Tykodi, Scott S.
    Chow, Laura Q. M.
    Hwu, Wen-Jen
    Topalian, Suzanne L.
    Hwu, Patrick
    Drake, Charles G.
    Camacho, Luis H.
    Kauh, John
    Odunsi, Kunle
    Pitot, Henry C.
    Hamid, Omid
    Bhatia, Shailender
    Martins, Renato
    Eaton, Keith
    Chen, Shuming
    Salay, Theresa M.
    Alaparthy, Suresh
    Grosso, Joseph F.
    Korman, Alan J.
    Parker, Susan M.
    Agrawal, Shruti
    Goldberg, Stacie M.
    Pardoll, Drew M.
    Gupta, Ashok
    Wigginton, Jon M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) : 2455 - 2465
  • [2] Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
    Brahmer, Julie R.
    Drake, Charles G.
    Wollner, Ira
    Powderly, John D.
    Picus, Joel
    Sharfman, William H.
    Stankevich, Elizabeth
    Pons, Alice
    Salay, Theresa M.
    McMiller, Tracee L.
    Gilson, Marta M.
    Wang, Changyu
    Selby, Mark
    Taube, Janis M.
    Anders, Robert
    Chen, Lieping
    Korman, Alan J.
    Pardoll, Drew M.
    Lowy, Israel
    Topalian, Suzanne L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) : 3167 - 3175
  • [3] Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes
    Carretero, Rafael
    Wang, Ena
    Rodriguez, Ana I.
    Reinboth, Jennifer
    Ascierto, Maria L.
    Engle, Alyson M.
    Liu, Hui
    Camacho, Francisco M.
    Marincola, Francesco M.
    Garrido, Federico
    Cabrera, Teresa
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (02) : 387 - 395
  • [4] Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells
    Carretero, Rafael
    Cabrera, Teresa
    Gil, Hernani
    Saenz-Lopez, Pablo
    Maleno, Isabel
    Aptsiauri, Natalia
    Cozar, Jose M.
    Garrido, Federico
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (04) : 839 - 846
  • [5] A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice
    Casares, Noelia
    Rudilla, Francesc
    Arribillaga, Laura
    Llopiz, Diana
    Ignacio Riezu-Boj, Jose
    Lozano, Teresa
    Lopez-Sagaseta, Jacinto
    Guembe, Laura
    Sarobe, Pablo
    Prieto, Jesus
    Borras-Cuesta, Francisco
    Jose Lasarte, Juan
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 185 (09) : 5150 - 5159
  • [6] The immune contexture in human tumours: impact on clinical outcome
    Fridman, Wolf Herman
    Pages, Franck
    Sautes-Fridman, Catherine
    Galon, Jerome
    [J]. NATURE REVIEWS CANCER, 2012, 12 (04) : 298 - 306
  • [7] A human memory T cell subset with stem cell-like properties
    Gattinoni, Luca
    Lugli, Enrico
    Ji, Yun
    Pos, Zoltan
    Paulos, Chrystal M.
    Quigley, Maire F.
    Almeida, Jorge R.
    Gostick, Emma
    Yu, Zhiya
    Carpenito, Carmine
    Wang, Ena
    Douek, Daniel C.
    Price, David A.
    June, Carl H.
    Marincola, Francesco M.
    Roederer, Mario
    Restifo, Nicholas P.
    [J]. NATURE MEDICINE, 2011, 17 (10) : 1290 - U325
  • [8] Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice
    Gonzalez-Aparicio, Manuela
    Alzuguren, Pilar
    Mauleon, Itsaso
    Medina-Echeverz, Jose
    Hervas-Stubbs, Sandra
    Mancheno, Uxua
    Berraondo, Pedro
    Crettaz, Julien
    Gonzalez-Aseguinolaza, Gloria
    Prieto, Jesus
    Hernandez-Alcoceba, Ruben
    [J]. GUT, 2011, 60 (03) : 341 - 349
  • [9] Maximal T Cell-Mediated Antitumor Responses Rely upon CCR5 Expression in Both CD4+ and CD8+ T Cells
    Gonzalez-Martin, Alicia
    Gomez, Lucio
    Lustgarten, Joseph
    Mira, Emilia
    Manes, Santos
    [J]. CANCER RESEARCH, 2011, 71 (16) : 5455 - 5466
  • [10] Hallmarks of Cancer: The Next Generation
    Hanahan, Douglas
    Weinberg, Robert A.
    [J]. CELL, 2011, 144 (05) : 646 - 674